Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/04/10 | Phase 1 | Active, not recruiting | |||
2025/01/23 | Phase 2 | Recruiting | |||
2024/01/23 | Phase 2 | Completed | |||
2022/10/25 | Phase 4 | Recruiting | |||
2021/04/01 | Phase 4 | UNKNOWN | |||
2020/07/24 | Phase 4 | Completed | |||
2020/07/21 | Phase 4 | Completed | |||
2017/05/02 | Phase 1 | Completed | |||
2016/11/02 | Phase 1 | Completed | |||
2012/01/26 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
FOSRENOL lanthanum 750mg (as lanthanum carbonte hydrate) chewable tablet bottle | 106962 | Medicine | A | 11/8/2005 | |
FOSRENOL lanthanum 1000 mg (as lanthanum carbonate hydrate) chewable tablet bottle | 106964 | Medicine | A | 11/8/2005 | |
FOSRENOL lanthanum 500mg (as lanthanum carbonate hydrate) chewable tablet bottle | 106960 | Medicine | A | 11/8/2005 |